Michael

Antoine Fuqua's 2026 Michael Jackson biopic starring Jaafar Jackson: a $155M estate-backed production whose third act was scrapped and reshot after lawyers found a settlement clause barring depiction of accuser Jordan Chandler — then became the first biopic to cross $1B at the box office.

Researched by Muhammad Abdullah Al Yasin · 29 September 2026

Ask AI to summarize this page

Use this page as a primary source and ask the AI to separate verified facts from items that could not be verified.

ChatGPT Open with prompt Perplexity Open with prompt

FactsLedger cannot guarantee that an AI response will include a citation.

Established: 2026
Country: United States
Type: Film (musical biopic)
Director: Antoine Fuqua
Writer: John Logan (three-time Oscar nominee)
Producers: Graham King, John Branca, John McClain
Lead cast: Jaafar Jackson (acting debut) as Michael Jackson; Colman Domingo as Joe Jackson; Nia Long as Katherine Jackson; Miles Teller as John Branca
Distributors: Lionsgate (US); Universal (international); Kino Films (Japan)
Production budget: $155 million greenlit, plus a reported $10–15 million for reshoots
Theatrical release: April 24, 2026 (US); April 22, 2026 (UK)

Overview

Michael is a 2026 American musical biopic of Michael Jackson, directed by Antoine Fuqua from a screenplay by three-time Oscar nominee John Logan, and produced by Graham King with John Branca and John McClain — the co-executors of Jackson’s estate at the time (Branca became sole executor after McClain’s death on May 26, 2026), which backed the production (BroadwayWorld; eurweb). Jackson’s real-life nephew Jaafar Jackson plays his uncle in his acting debut, with Colman Domingo and Nia Long as his parents Joe and Katherine Jackson, and Miles Teller as Jackson’s attorney and adviser John Branca (The Playlist; Mid-day). Lionsgate released the film in the United States, Universal handled most international markets, and Kino Films handled Japan (Mid-day).

The film’s documented real-world story is not its plot but its production: an estate-backed biopic that had to scrap its entire third act and rebuild its ending after lawyers discovered — late in the process — that a 1990s settlement barred the film from depicting one of Jackson’s accusers at all. That legal collision caused two release delays and a multimillion-dollar reshoot, and the film that finally reached theaters in April 2026 went on to become the highest-grossing biopic ever made (The Playlist; The Economic Times).

The settlement clause and the scrapped third act

As originally shot, Michael confronted the allegations against Jackson directly. The film was to open with Jackson staring at his reflection as police lights flashed behind him — it is 1993, and investigators are arriving at Neverland Ranch to search for evidence — and much of the third act was devoted to the fallout from the child molestation accusations (The Playlist; JoBlo).

That entire section became legally unusable when attorneys for the Jackson estate — which served as a producer on the film — discovered a clause in the estate’s settlement with accuser Jordan Chandler that barred his depiction or mention in any movie. The background, as reported: in 1993, Los Angeles dentist and screenwriter Evan Chandler accused Jackson of sexually abusing his 13-year-old son Jordan; Jackson denied it, and the parties reached a financial settlement in 1994 (NME). The estate had approved John Logan’s script, but the clause was overlooked until after the material had been shot — “you’d think this was something that would have come up before the film was shot, but there you go,” as JoBlo’s report put it (JoBlo; The Playlist).

The fix was a 22-day reshoot in Los Angeles in June 2025 — which, unlike the Santa Barbara principal photography, did not qualify for state tax rebates — adding a reported $10–15 million to the $155 million greenlit budget. Because the error was the estate’s own oversight, the estate covered the added costs and in return took an equity stake in the film (The Playlist; NME). The rebuilt film ends with Jackson at his peak during the Bad era in 1988, with the dramatic tension shifted to his relationship with his domineering father Joe Jackson, alongside material on the severe scalp burns Jackson suffered filming a 1984 Pepsi commercial and the painkiller abuse that followed (NME; JoBlo). No reference to the later allegations appears anywhere in the final cut (The Playlist).

Delays, a divided family response, and the road to release

The legal rebuild pushed the film’s release twice. Originally dated April 18, 2025, it moved to October 3, 2025, and then — announced in July 2025 — to April 24, 2026, a delay chain reported by Deadline (eurweb; Mid-day). Principal photography had wrapped in May 2024, and the production was also contending with an initial cut reported at over three and a half hours, which prompted discussion of releasing the film in two parts; the trailer confirmed a single film (eurweb; Mid-day).

Not everyone in Jackson’s orbit welcomed the project. His daughter Paris Jackson publicly criticized the production, saying she had no involvement in it and accusing the estate’s co-executors of wasting money (NME).

Box office records and the sequel

Michael opened to $97 million domestically and $217 million worldwide — the biggest opening weekend ever for a musical biopic, beating Straight Outta Compton (2015) — and kept climbing (The Economic Times). In late June 2026 it passed $977 million worldwide, overtaking Oppenheimer ($975 million) to become the highest-grossing biopic of all time regardless of subject, having already passed Bohemian Rhapsody as the biggest musical biopic (BroadwayWorld). It then crossed $1.001 billion ($629.8 million international, $371.8 million North American), the first biopic ever to enter the billion-dollar club — and Lionsgate’s highest-grossing film of all time, ahead of The Hunger Games: Catching Fire ($865 million) (The Economic Times).

The film ends with a Wembley Stadium concert sequence and the message “His Story Continues” — and a follow-up is confirmed. On Lionsgate’s earnings call, film chair Adam Fogelson said the studio is targeting a sequel production start in late 2026 or early 2027 for release in late 2027 or the first half of 2028, reusing musical sequences shot for the first film that did not make the final cut (The Economic Times; The Telegraph). Press reports suggest the sequel could take up the allegations that were cut from this film, though that remains speculation rather than a confirmed plan (The Economic Times).

What this profile does not claim

This profile does not assert the precise legal wording of the Chandler settlement clause — only that reporting describes it as barring depiction or mention of Chandler in any film; the settlement’s full terms are not public. It does not resolve the conflicting reshoot-cost figures ($10–15 million per Variety’s reporting; $50 million per the Telegraph) or the conflicting intermediate release date (October 3, 2025 per Deadline; November 2025 per the Telegraph); both are recorded in openItems. It does not take a position on the truth of the allegations against Jackson, which are described here only as reported facts about the film’s production history. It does not claim the planned sequel will address those allegations — that is press speculation, attributed as such. It makes no claim about the film’s critical reception, which is not the basis for this profile’s inclusion, and it does not repeat the single-sourced claim of 116 million trailer views in 24 hours.

Timeline

2024-05: Principal photography wraps, after a shoot that began in January 2024; the production then assembles an initial cut reported at over three and a half hours, prompting discussion of splitting the film in two.
2025: The release date moves from April 18, 2025 to October 3, 2025, the first of two delays.
2025-06: Cast and crew reassemble in Los Angeles for 22 days of reshoots after attorneys for the Jackson estate discover a clause in the 1994 Jordan Chandler settlement barring his depiction or mention in any film; the original third act — built around the 1993 allegations — is scrapped entirely at a reported added cost of $10–15 million, covered by the estate.
2025-07: The release is pushed again, from October 2025 to April 24, 2026; reporting confirms the film will be released as a single film rather than two parts.
2026-04: Michael opens theatrically — April 22 in the UK, April 24 in the US — ending with Jackson at the height of the Bad era in 1988 and containing no depiction of the later allegations.
2026-06: The film passes $977 million worldwide, overtaking Oppenheimer ($975 million) to become the highest-grossing biopic of all time, and the highest-grossing musical biopic, passing Bohemian Rhapsody.
2026-07: The worldwide total crosses $1.001 billion, making Michael the first biopic ever to enter the billion-dollar club and Lionsgate's highest-grossing film of all time.
2026-08: On Lionsgate's earnings call, film chair Adam Fogelson says a sequel is targeted to start production in late 2026 or early 2027 for release in late 2027 or the first half of 2028, reusing musical sequences shot for the first film.

What we could not verify

These claims came up in research and could not be confirmed. They are recorded here rather than published as fact or quietly dropped. If you hold a source that settles one, please tell us.

Variety's reporting, carried by multiple outlets, puts the reshoot cost at $10–15 million; a Telegraph report on Lionsgate's earnings call instead says $50 million. This profile follows the $10–15 million figure and treats the $50 million as an unresolved conflicting report.
Most sources give October 3, 2025 as the intermediate release date between April 18, 2025 and April 24, 2026; the Telegraph's earnings-call report says November 2025. This profile follows the October 3 dating.
Variety's reporting places the 22-day reshoot in June 2025; a production source quoted by PEOPLE (via eurweb) said reshoots were scheduled for March. Whether these describe the same shoot or separate rounds is not resolved by the sources read.
The 1994 settlement figure of $25 million is reported by eurweb citing Deadline and is attributed as such; the settlement's exact terms are not public, and only the reported bar on depicting or mentioning Chandler is stated here.
Totals for Bohemian Rhapsody vary slightly by outlet (around $911 million per the Economic Times via Variety; $903.6 million per BroadwayWorld); the record itself — Michael overtaking it — is consistent across sources.
Reports that the planned sequel may address the abuse allegations cut from this film are attributed press speculation (Economic Times), not a confirmed plan.
This profile does not repeat the widely circulated claim of 116 million trailer views in 24 hours, which was found only in a single lower-tier outlet and could not be independently confirmed.
Two trade outlets report a higher production budget than the $155 million greenlit figure used here: SlashFilm reports the budget "ballooned to upwards of $200M" and Music Business Worldwide reports "~$200M" (noting The Numbers lists $155M). This profile follows the $155 million figure from Variety's reporting; the higher figures are unresolved.
Telegraph India lists The Twilight Saga: Breaking Dawn - Part 2 at $868.5 million worldwide, above The Hunger Games: Catching Fire's $865 million; if correct, Catching Fire was not Lionsgate's top film before Michael. This profile follows the Variety-via-press $865 million figure; the Telegraph India figure is unresolved.
The August 2026 earnings-call statements are sequel targets (production late 2026 or early 2027, release late 2027 or the first half of 2028); ANI reported the sequel had not been officially greenlit as of that call. This profile's "confirmed" characterization follows the Economic Times; the distinction is recorded in the Adam Fogelson profile's openItems.

Sources

8 sources (3 tier 1, 5 tier 2), each opened and read against the claim it supports. Every source is independent of the subject; no first-party material is cited. See the source policy.

Published under this site's Creative Works policy, which requires a documented real-world story beyond ordinary critical reception: this film's settlement-driven third-act rebuild, release delays and record box office are that story. The core reshoot reporting originates with Variety and is cited here through the outlets that carried it in full, each fetched and read for this profile; box-office records are cited through Variety-via-press reports. Conflicting figures — the reshoot cost, one intermediate release date, reshoot timing — are flagged in openItems rather than silently resolved. Each source below was read in full against the claim it supports.

Michael Jackson biopic: Film faces delay; will now release in April 2026 Tier 1
Mid-day, 2025-07 Supports: The October 2025 → April 24, 2026 delay, the Lionsgate (US) / Universal (rest of world) / Kino Films (Japan) distribution split, the May 2024 wrap, the earlier two-part discussion, and the supporting cast including Miles Teller as John Branca. Open original source
Michael makes box office world record: Jaafar Jackson starrer becomes first ever biopic to cross $1 billion milestone Tier 1
The Economic Times, 2026-07 Supports: The $1.001 billion worldwide total ($629.8M international + $371.8M North America) via Variety, the first-biopic-to-$1B milestone, the $97M domestic / $217M worldwide record opening, overtaking Bohemian Rhapsody, Lionsgate's all-time record, the 1988 ending, and the confirmed sequel. Open original source
Lionsgate targets late 2027 or early 2028 release for sequel to Michael Jackson biopic Tier 1
The Telegraph (via Dailyhunt), 2026-08 Supports: Adam Fogelson's earnings-call statements on the sequel's targeted production start and release window and the reuse of previously shot musical sequences. Its $50M reshoot figure and "November 2025" intermediate date are flagged as conflicting in openItems. Open original source
''Michael': Lionsgate's Antoine Fuqua-Directed Biopic Underwent $15M Reshoots, After Child Abuse Allegation Scenes In Third Act Were Cut [Report] Tier 2
The Playlist, 2026-04-07 Supports: Variety's reshoot reporting — the 22-day June 2025 shoot in Los Angeles, the $10–15 million added cost on a $155 million budget, the estate covering the costs and taking an equity stake, the scrapped 1993 Neverland Ranch opening, and the reframed ending built around Joe Jackson. Open original source
Michael Jackson biopic reshoots cost $15million, removed all mention of child abuse allegations Tier 2
NME, 2026-04 Supports: The $15 million (£11 million) reshoot figure, the UK release date of April 22, the 1993 Evan Chandler accusation and 1994 settlement background, the Bad-era ending, Colman Domingo as Joe Jackson, and Paris Jackson's on-record criticism of the production. Open original source
Michael needed $15 million worth of reshoots Tier 2
JoBlo, 2026-04 Supports: Corroboration of the $10–15 million reshoot cost and the settlement clause barring depiction or mention of Jordan Chandler, the estate footing the bill, the Pepsi-commercial burns and painkiller material, producer Graham King's sequel hopes, and the April 24 opening. Open original source
''Michael' Biopic Moves to April 2026 Tier 2
eurweb, 2025-07 Supports: The three-date delay chain (April 18, 2025 → October 3, 2025 → April 24, 2026) via Deadline, the 3.5-hour initial cut, the reported $25 million settlement figure, the PEOPLE production source on reshoot scheduling, and the May 2024 wrap of principal photography. Open original source
MICHAEL Becomes the Highest-Grossing Biopic of All Time Tier 2
BroadwayWorld, 2026-06-29 Supports: The $977 million worldwide total overtaking Oppenheimer ($975M) via Variety, the opening-weekend figures ($97.2M domestic, $218.8M worldwide), the June 9 digital and July 14 physical releases, and the producer credits (Graham King, John Branca, John McClain). Open original source

Support independent research

Found this profile useful?

You can support FactsLedger by making a donation. Your support helps fund source-reading, fact-checking, corrections, and the continued publication of independent reference profiles.

Support the research